Pfizer Sees 5% Growth In Second Half; Currency, Competition Hurt Sales
Pfizer's revised forecast for 2004 revenues indicates that the company expects sales growth of about 5% during the second half of the year
Pfizer's revised forecast for 2004 revenues indicates that the company expects sales growth of about 5% during the second half of the year